PubMed:17151160 / 0-273 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":104},"obj":"Sentence"},{"id":"T2","span":{"begin":105,"end":122},"obj":"Sentence"},{"id":"T3","span":{"begin":123,"end":133},"obj":"Sentence"}],"text":"Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.\nOBJECTIVE: The authors compared 4-month treatment outcomes for olanzapine versus risperidone in patients with first-episode schizophrenia spectrum dis"}

{"project":"LitCoin-entities","denotations":[{"id":"3660","span":{"begin":25,"end":35},"obj":"ChemicalEntity"},{"id":"3661","span":{"begin":43,"end":54},"obj":"ChemicalEntity"},{"id":"3662","span":{"begin":90,"end":103},"obj":"DiseaseOrPhenotypicFeature"},{"id":"3663","span":{"begin":186,"end":196},"obj":"ChemicalEntity"},{"id":"3664","span":{"begin":204,"end":215},"obj":"ChemicalEntity"},{"id":"3665","span":{"begin":247,"end":260},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"db_id","subj":"3660","obj":"MESH:C076029"},{"id":"A2","pred":"db_id","subj":"3661","obj":"MESH:D018967"},{"id":"A3","pred":"db_id","subj":"3662","obj":"MESH:D012559"},{"id":"A4","pred":"db_id","subj":"3663","obj":"MESH:C076029"},{"id":"A5","pred":"db_id","subj":"3664","obj":"MESH:D018967"},{"id":"A6","pred":"db_id","subj":"3665","obj":"MESH:D012559"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.\nOBJECTIVE: The authors compared 4-month treatment outcomes for olanzapine versus risperidone in patients with first-episode schizophrenia spectrum dis"}

{"project":"LitCoin_Mondo","denotations":[{"id":"T1","span":{"begin":90,"end":106},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":90,"end":103},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":247,"end":260},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0010943"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0005090"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0005090"}],"text":"Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.\nOBJECTIVE: The authors compared 4-month treatment outcomes for olanzapine versus risperidone in patients with first-episode schizophrenia spectrum dis"}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T1","span":{"begin":90,"end":103},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":247,"end":260},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"originalLabel","subj":"T1","obj":"D012559"},{"id":"A2","pred":"originalLabel","subj":"T2","obj":"D012559"}],"text":"Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.\nOBJECTIVE: The authors compared 4-month treatment outcomes for olanzapine versus risperidone in patients with first-episode schizophrenia spectrum dis"}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T1","span":{"begin":90,"end":106},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":247,"end":260},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0010943"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0005090"}],"text":"Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.\nOBJECTIVE: The authors compared 4-month treatment outcomes for olanzapine versus risperidone in patients with first-episode schizophrenia spectrum dis"}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T1","span":{"begin":90,"end":103},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":247,"end":260},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"D012559"},{"id":"A2","pred":"ID:","subj":"T2","obj":"D012559"}],"text":"Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.\nOBJECTIVE: The authors compared 4-month treatment outcomes for olanzapine versus risperidone in patients with first-episode schizophrenia spectrum dis"}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T1","span":{"begin":90,"end":103},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":247,"end":260},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"#label","subj":"T1","obj":"D012559"},{"id":"A2","pred":"#label","subj":"T2","obj":"D012559"}],"text":"Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.\nOBJECTIVE: The authors compared 4-month treatment outcomes for olanzapine versus risperidone in patients with first-episode schizophrenia spectrum dis"}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T1","span":{"begin":25,"end":35},"obj":"ChemicalEntity"},{"id":"T3","span":{"begin":43,"end":54},"obj":"ChemicalEntity"},{"id":"T5","span":{"begin":186,"end":196},"obj":"ChemicalEntity"},{"id":"T7","span":{"begin":204,"end":215},"obj":"ChemicalEntity"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"D000077152"},{"id":"A2","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_7735"},{"id":"A3","pred":"ID:","subj":"T3","obj":"D018967"},{"id":"A4","pred":"ID:","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_8871"},{"id":"A5","pred":"ID:","subj":"T5","obj":"D000077152"},{"id":"A6","pred":"ID:","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_7735"},{"id":"A7","pred":"ID:","subj":"T7","obj":"D018967"},{"id":"A8","pred":"ID:","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_8871"}],"text":"Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.\nOBJECTIVE: The authors compared 4-month treatment outcomes for olanzapine versus risperidone in patients with first-episode schizophrenia spectrum dis"}

{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T1","span":{"begin":219,"end":227},"obj":"OrganismTaxon"}],"text":"Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.\nOBJECTIVE: The authors compared 4-month treatment outcomes for olanzapine versus risperidone in patients with first-episode schizophrenia spectrum dis"}

{"project":"LitCoin-training-merged","denotations":[{"id":"T7","span":{"begin":204,"end":215},"obj":"ChemicalEntity"},{"id":"T5","span":{"begin":186,"end":196},"obj":"ChemicalEntity"},{"id":"T3","span":{"begin":43,"end":54},"obj":"ChemicalEntity"},{"id":"T1","span":{"begin":25,"end":35},"obj":"ChemicalEntity"},{"id":"T2","span":{"begin":247,"end":260},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T53300","span":{"begin":90,"end":103},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T71762","span":{"begin":219,"end":227},"obj":"OrganismTaxon"}],"attributes":[{"id":"A8","pred":"ID:","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_8871"},{"id":"A7","pred":"ID:","subj":"T7","obj":"D018967"},{"id":"A6","pred":"ID:","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_7735"},{"id":"A5","pred":"ID:","subj":"T5","obj":"D000077152"},{"id":"A4","pred":"ID:","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_8871"},{"id":"A3","pred":"ID:","subj":"T3","obj":"D018967"},{"id":"A2","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_7735"},{"id":"A1","pred":"ID:","subj":"T1","obj":"D000077152"},{"id":"A20808","pred":"#label","subj":"T2","obj":"D012559"},{"id":"A52994","pred":"#label","subj":"T53300","obj":"D012559"}],"text":"Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.\nOBJECTIVE: The authors compared 4-month treatment outcomes for olanzapine versus risperidone in patients with first-episode schizophrenia spectrum dis"}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":247,"end":260},"obj":"HP_0100753"}],"text":"Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.\nOBJECTIVE: The authors compared 4-month treatment outcomes for olanzapine versus risperidone in patients with first-episode schizophrenia spectrum dis"}